Sector Healthcare Value B USD |
Performance History | 30/04/2024 |
Growth of 1,000 (EUR) |
Fund | -1.1 | 17.4 | 4.5 | -3.1 | 1.0 | |
+/-Cat | -12.3 | 0.7 | 14.3 | -2.3 | -2.4 | |
+/-Idx | - | -8.7 | 4.4 | -2.9 | -5.3 | |
Category: Sector Equity Healthcare | ||||||
Benchmarks: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 16/05/2024 | USD 168.77 | |
Day Change | -0.26% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | IE00BD4TRB36 | |
Fund Size (Mil) 16/05/2024 | USD 429.73 | |
Share Class Size (Mil) 16/05/2024 | USD 60.54 | |
Max Initial Charge | - | |
Ongoing Charge 18/04/2024 | 2.25% |
Investment Objective: Sector Healthcare Value B USD |
The investment process behind Sector Healthcare Value Fund is based on a fundamentally driven model for bottom up stock valuation within the global Healthcare and Biotech sector. The portfolio will contain 20-40 long positions. Value creation and valuation: Valuation is the single most important factor in the investment team's model. Several valuation models are used, and they based on an in-house view on normalised earnings, future growth/returns and the duration of the growth. Momentum and sentiment: The investment team also considers more short term factors which can modify their long-term fundamental view. The investment team may also take risk on these factors unless the company is significantly overvalued. Portfolio construction: the investment manager considers the degree of mis-pricing given by the scorecard model relative to the total risk of the individual security expressed through the security's history and options' implied volatility. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Trond Horneland 16/11/2010 | ||
Inception Date 23/02/2017 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Sector Healthcare Value B USD | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
GSK PLC | Healthcare | 7.40 |
Roche Holding AG | Healthcare | 6.25 |
Medtronic PLC | Healthcare | 5.48 |
Pfizer Inc | Healthcare | 5.02 |
Sanofi SA | Healthcare | 4.42 |
Increase Decrease New since last portfolio | ||
Sector Healthcare Value B USD |